Chimeric receptor molecules for delivery of co-stimulatory signals

• US 5,686,281 A
• Filed: 05/31/1995
• Issued: 11/11/1997
• Est. Priority Date: 02/03/1995
• Status: Expired due to Fees

• Current Assignee: Cell Genesys Incorporated (ANI Pharmaceuticals, Inc.)
• Original Assignee: Cell Genesys Incorporated (ANI Pharmaceuticals, Inc.)
• Inventors: Roberts, Margo R.
• Primary Examiner(s): ULM, JOHN D
• Application Number:
  US08/455,860
• Time in Patent Office: 895 Days
• Field of Search: 435/7.1, 435/7.2, 435/64.7, 435/172.3, 435/252.3, 435/320.1, 536/23.4
• US Class Current: 435/456
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: C07K 14/55 IL-2
• CPC Class Codes: C07K 14/705 Receptors; Cell surface antigens; Cell surface determinants tumour specific antigens C07K14/4748
• CPC Class Codes: C07K 14/70507 CD2
• CPC Class Codes: C07K 14/7051 T-cell receptor (TcR)-CD3 complex
• CPC Class Codes: C07K 14/70514 CD4
• CPC Class Codes: C07K 14/70521 CD28, CD152
• CPC Class Codes: C07K 14/70528 CD58
• CPC Class Codes: C07K 2319/00 Fusion polypeptide

Abstract

The present invention is directed to novel chimeric co-stimulatory receptor proteins and DNA sequences encoding these proteins. The chimeric receptors comprise at least three domains in a single chain molecule: an extracellular ligand binding domain, a transmembrane domain and a cytoplasmic co-stimulatory effector function signaling domain that acts synergistically with an effector function signal in the host cell. Novel hybrid co-stimulatory receptor proteins include a second cytoplasmic effector function signaling domain. The invention further relates to expression cassettes containing the nucleic acids encoding the novel chimeric receptors, to host cells expressing the novel chimeric receptors and to methods of using the receptors to co-stimulate effector functions in the cells and for using cells expressing the receptors for treatment of cancer, disease and viral infections.

Claims

1. A method for augmenting an immune cell effector function by providing a co-stimulatory signal to a host cell comprising:

a) introducing a DNA expressing a chimeric co-stimulatory receptor protein into a host cell under conditions suitable for expression of said chimeric receptor protein to produce receptor-expressing cells; and

b) contacting said receptor-expressing cells with a target ligand, wherein said chimeric receptor protein comprises in the N-terminal to c-terminal direction;

an extracellular ligand-binding domain that binds said target ligand;

a transmembrane domain; and

a cytoplasmic co-stimulatory domain;

wherein said cytoplasmic domain is CD2 or CD28; and

wherein said extracellular domain is not obtained from CD2 or CD28.

2. The method of claim 1 wherein the extracellular domain is CD4.

3. The method of claim 1 wherein the host cell is an immune cell.

4. The method of claim 1 wherein the host cell is a lymphocyte or hematopoietic stem cell.

5. The method of claim 1 wherein the effector function is cytolytic activity of the host cell.

6. The method of claim 1 wherein the effector function is cytokine production.

7. The method of claim 1 wherein the effector function is resistance of the host cell to anergy.

8. The method of claim 1 wherein the effector function is proliferation of the host cell.

9. The method of claim 1 wherein the effector function is differentiation, maturation or both of the host cell.

10. The method of claim 1 wherein the host cell expresses a chimeric effector function signaling receptor protein comprising an extracellular ligand binding domain, a transmembrane domain and a cytoplasmic effector function signaling domain.

11. The method of claim 1, wherein said protein further comprises a cytoplasmic effector signaling domain.